Inflammatory, Cardiac, and Lipid-Related Biomarkers in Relation to Residual MACE Risk in the REPRIEVE Trial. - Grinspoon SK; DeFilippi C; Umbleja T; McCallum S; Christenson RH; Chu SM; Lu AB; Burdo TH; Aberg JA; Fichtenbaum CJ; Bloomfield GS; Malvestutto CD; et al. (JACC. Advances, 2026)